The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|January 1, 1997
Supplements and Featured Publications
- Managing Hypercholesterolemia and Coronary Heart Disease
- Volume 3
- Issue 1 Suppl
Clinical Study Outcomes and the Benefits of Treating Hypercholesterolemia
Advertisement
Articles in this issue
almost 30 years ago
MCO Decisions and Solutionsalmost 30 years ago
The Importance of Lipid Lowering and Other Risk Reduction Therapiesalmost 30 years ago
Matching Risks to Interventions: When to Treat, How to Treatalmost 30 years ago
CME Quizalmost 30 years ago
Bibliographyalmost 30 years ago
Participantsalmost 30 years ago
Goals and Objectivesalmost 30 years ago
Introductionalmost 30 years ago
Goals for Patient Treatmentalmost 30 years ago
Pharmacoeconomics: The Cost Effectiveness of Lipid ManagementAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
3
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
4
Tarlatamab Plus Durvalumab Cuts Risk of Death by 58% as First-Line Maintenance in ES-SCLC
5